| Literature DB >> 31428134 |
Qian Zhang1,2,3, Yang Yu1,2, Quanchao Wang1, Fei Liu1, Zheng Luo1,3, Chengsong Zhang1,2, Xiaojun Zhang1,2, Hao Huang4, Jianhai Xiang1,2, Fuhua Li1,2,5.
Abstract
Acute hepatopancreatic necrosis disease (AHPND) is a major bacterial disease in Pacific white shrimp Litopenaeus vannamei farming, which is caused by Vibrio parahaemolyticus. AHPND has led to a significant reduction of shrimp output since its outbreak. Selective breeding of disease-resistant broodstock is regarded as a key strategy in solving the disease problem. Understanding the relationship between genetic variance and AHPND resistance is the basis for marker-assisted selection in shrimp. The purpose of this study was to identify single nucleotide polymorphisms (SNPs) associated with the resistance against AHPND in L. vannamei. In this work, two independent populations were used for V. parahaemolyticus challenge and the resistant or susceptible shrimp were evaluated according to the survival time after Vibrio infection. The above two populations were genotyped separately by a SNP panel designed based on the target sequencing platform using a pooling strategy. The SNP panel contained 508 amplicons from DNA fragments distributed evenly along the genome and some immune-related genes of L. vannamei. By analyzing the allele frequency in the resistant and susceptible groups, 30 SNPs were found to be significantly associated with the resistance of the shrimp against V. parahaemolyticus infection (false discovery rate corrected at P < 0.05). Three SNPs were further validated by individual genotyping in all samples of population 1. Our study illustrated that target sequencing and pooling sequencing were effective in identifying the markers associated with economic traits, and the SNPs identified in this study could be used as molecular markers for breeding disease-resistant shrimp.Entities:
Keywords: association analysis; disease resistance; penaeid shrimp; single nucleotide polymorphism; target sequencing
Year: 2019 PMID: 31428134 PMCID: PMC6688095 DOI: 10.3389/fgene.2019.00700
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Primer sequences and corresponding annealing temperature of genes.
| Primer name | Primer sequence (5′-3′) | Expected size (bp) | Annealing temperature (°C) |
|---|---|---|---|
| LvALF-F | GGTGACCAGACCTGCTTTGAG | 290 | 58 |
| LvALF-R | CCAGCTAGGATAACCGTAACATG | ||
| Lv2060-F | TCTTACACACATTCTTCCTGGT | 190 | 58 |
| Lv2060-R | AGAAGTCGTTTGGGGAGATTGT | ||
| qLvALF-F | GGTTTGGCTTCTTCCTCGGT | 100 | 56 |
| qLvALF-R | CCAACACCCGCAGCAAAT | ||
| qLvPI3K-F | AATGGTCGTCAAGCAATGTGG | 111 | 56 |
| qLvPI3K-R | TGTCTAATGTGAGCAAGTCTGTCC | ||
| 18S-F | TATACGCTAGTGGAGCTGGAA | 136 | 56 |
| 18S-R | GGGGAGGTAGTGACGAAAAAT |
Figure 1Accumulated mortality rates of populations 1 and 2 infected with V. parahaemolyticus and PBS. PL1, population 1; PL2, population 2.
Loads of V. parahaemolyticus in hepatopancreas, gill, and muscle of shrimp.
| dpi | Hepatopancreas (CFU/g) | Gill (CFU/g) | Muscle (CFU/g) | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1.49×103 | 9.80×102 | 9.73×103 | 4.06×103 | 7.78×103 | 7.46×102 |
| 2 | 1.40×106 | 1.63×106 | 3.82×103 | 2.09×103 | 2.43×105 | 1.06×105 |
| 3 | 4.76×105 | 8.06×103 | 6.74×103 | 1.42×103 | 2.89×104 | 2.47×104 |
| 8 | 4.82×103 | 3.95×103 | 5.25×102 | 7.50×10 | 3.11×105 | 1.80×105 |
| 12 | 1.12×103 | 2.81×10 | 5.88×102 | 1.47×102 | 6.85×102 | 1.71×102 |
Figure 2-log10(adjusted P) of 1556 SNPs (filtering out 10 false-positive sites) in a combined population and the threshold for significance is FDR-corrected P < 0.05.
χ2 test and allele frequency distribution of SNP markers with significant difference (FDR-corrected P < 0.05) in two populations.
| SNPs | FDR-corrected | Ref | P1S1 | P1S2 | P2S1 | P2S2 | Average | P1R1 | P1R2 | P2R1 | P2R2 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marker15416_294 | 9.32E-04 | A | 0.26 | 0.37 | 0.47 | 0.28 | 0.35 | 0.18 | 0.13 | 0.11 | 0.21 | 0.16 |
| Marker8720_486 | 0.002 | A | 0.60 | 0.67 | 0.61 | 0.62 | 0.63 | 0.50 | 0.52 | 0.33 | 0.36 | 0.43 |
| Marker1077_61 | 0.002 | T | 0.52 | 0.49 | 0.57 | 0.64 | 0.56 | 0.43 | 0.43 | 0.17 | 0.38 | 0.35 |
| Marker1077_126 | 0.004 | C | 0.59 | 0.52 | 0.59 | 0.63 | 0.58 | 0.44 | 0.53 | 0.18 | 0.41 | 0.39 |
| Marker1077_72 | 0.005 | C | 0.70 | 0.59 | 0.67 | 0.75 | 0.68 | 0.51 | 0.56 | 0.28 | 0.58 | 0.48 |
| Marker1077_65 | 0.005 | T | 0.70 | 0.58 | 0.67 | 0.75 | 0.67 | 0.51 | 0.56 | 0.28 | 0.58 | 0.48 |
| Marker1077_146 | 0.005 | T | 0.60 | 0.52 | 0.60 | 0.64 | 0.59 | 0.47 | 0.52 | 0.20 | 0.43 | 0.41 |
| Marker1077_134 | 0.005 | C | 0.61 | 0.52 | 0.59 | 0.64 | 0.59 | 0.46 | 0.55 | 0.20 | 0.42 | 0.41 |
| Marker1077_81 | 0.006 | C | 0.70 | 0.58 | 0.67 | 0.74 | 0.67 | 0.51 | 0.56 | 0.28 | 0.58 | 0.48 |
| Unigene2052_All__14026_558_197 | 0.006 | G | 0.84 | 0.94 | 0.79 | 0.80 | 0.84 | 0.96 | 0.97 | 0.92 | 0.97 | 0.96 |
| Marker1077_98 | 0.006 | C | 0.60 | 0.53 | 0.59 | 0.64 | 0.59 | 0.46 | 0.54 | 0.20 | 0.42 | 0.40 |
| Marker9677_156 | 0.006 | C | 0.44 | 0.57 | 0.52 | 0.50 | 0.51 | 0.65 | 0.60 | 0.71 | 0.77 | 0.68 |
| Marker2060_197 | 0.007 | T | 0.71 | 0.20 | 0.28 | 0.54 | 0.43 | 0.68 | 0.77 | 0.11 | 0.90 | 0.61 |
| ALF6-1__22575_510_57 | 0.008 | T | 0.39 | 0.35 | 0.37 | 0.58 | 0.42 | 0.59 | 0.55 | 0.58 | 0.68 | 0.60 |
| Unigene19157_All__1806_348_223 | 0.010 | C | 0.29 | 0.44 | 0.37 | 0.35 | 0.36 | 0.29 | 0.17 | 0.17 | 0.19 | 0.20 |
| Marker30980_113 | 0.010 | C | 0.81 | 0.82 | 0.87 | 0.84 | 0.84 | 0.82 | 0.71 | 0.55 | 0.67 | 0.69 |
| Marker4976_311 | 0.011 | A | 0.26 | 0.39 | 0.56 | 0.54 | 0.44 | 0.15 | 0.29 | 0.27 | 0.38 | 0.27 |
| Marker66_168 | 0.015 | A | 0.55 | 0.72 | 0.47 | 0.56 | 0.58 | 0.72 | 0.82 | 0.80 | 0.62 | 0.74 |
| Marker4976_524 | 0.015 | T | 0.73 | 0.56 | 0.52 | 0.44 | 0.56 | 0.88 | 0.64 | 0.76 | 0.64 | 0.73 |
| Marker17240_299 | 0.015 | C | 0.73 | 0.62 | 0.65 | 0.69 | 0.67 | 0.31 | 0.66 | 0.64 | 0.41 | 0.50 |
| Marker8591_231 | 0.017 | C | 0.25 | 0.44 | 0.48 | 0.49 | 0.41 | 0.31 | 0.18 | 0.34 | 0.16 | 0.25 |
| Marker66_291 | 0.018 | A | 0.42 | 0.27 | 0.34 | 0.18 | 0.30 | 0.11 | 0.24 | 0.15 | 0.16 | 0.16 |
| Marker4976_523 | 0.019 | T | 0.73 | 0.56 | 0.52 | 0.47 | 0.57 | 0.88 | 0.65 | 0.77 | 0.62 | 0.73 |
| Marker10592_316 | 0.027 | G | 0.89 | 0.90 | 1.00 | 0.97 | 0.94 | 0.78 | 0.75 | 0.93 | 0.87 | 0.83 |
| Marker4976_316 | 0.028 | G | 0.26 | 0.39 | 0.56 | 0.56 | 0.44 | 0.15 | 0.33 | 0.28 | 0.38 | 0.28 |
| Marker4311_49 | 0.040 | C | 0.01 | 0.10 | 0.10 | 0.11 | 0.08 | 0.18 | 0.06 | 0.35 | 0.16 | 0.19 |
| ALF6-1__22575_510_224 | 0.043 | G | 0.69 | 0.71 | 0.76 | 0.86 | 0.75 | 0.90 | 0.84 | 0.76 | 1.00 | 0.88 |
| Marker16977_128 | 0.045 | T | 0.92 | 0.84 | 0.63 | 0.77 | 0.79 | 0.90 | 0.95 | 0.88 | 0.87 | 0.90 |
| Marker10592_344 | 0.045 | C | 0.91 | 0.92 | 1.00 | 0.97 | 0.95 | 0.82 | 0.78 | 0.94 | 0.89 | 0.86 |
| Marker11943_195 | 0.049 | T | 0.39 | 0.29 | 0.31 | 0.44 | 0.36 | 0.19 | 0.13 | 0.32 | 0.25 | 0.22 |
Ref, allele frequency refers to the allele shown in the “Ref”; P1S1 and P1S2, allele frequency in susceptible bulk of population 1; P2S1 and P2S2, allele frequency in susceptible bulk of population 2; P1R1 and P1R, allele frequency in resistant bulk of population 1; P2R1 and P2R2, allele frequency in resistant bulk of population 2.
Figure 3-log10(adjusted P) of three SNPs, including loci Marker15416_294, Marker8720_486, and Marker1077_61 located in the fragment of Marker15416, (A) Marker8720 (B), and Marker1077 (C), respectively.
Distribution of the three markers in the susceptible and resistant groups of population 1.
| SNP | Genotype | Susceptible, n (%) | Resistant, n (%) | Total, n(%) |
|
|
|---|---|---|---|---|---|---|
| ALF6-1__22575_510_57 | A/A | 45 (37.5) | 20 (20.2) | 65 (29.7) | 7.7839 | 0.0204 |
| A/T | 28 (23.3) | 30 (30.3) | 58 (26.5) | |||
| T/T | 47 (39.2) | 49 (49.5) | 96 (43.8) | |||
| ALF6-1__22575_510_224 | A/A | 2 (1.68) | 3 (3) | 5 (2.28) | 7.0612 | 0.0293 |
| A/G | 43 (36.13) | 20 (20) | 63 (28.77) | |||
| G/G | 74 (62.18) | 77 (77) | 151 (68.95) | |||
| Marker2060_197 | T/T | 74 (62.71) | 75 (75) | 149 (68.35) | 6.9488 | 0.0310 |
| T/C | 10 (8.47) | 11 (11) | 21 (9.63) | |||
| C/C | 34 (28.81) | 14 (14) | 48 (22.02) |
*P < 0.05, significant difference of the genotype distributions between these two groups.
Information of associated regions and candidate gene identification.
| SNPs | LG* | Gene Annotation |
|---|---|---|
| Unigene2052_All__14026_558_197 | LG6 | Low molecular weight phosphotyrosine protein phosphatase-like |
| ALF6-1__22575_510_57 | LG30 | Anti-lipopolysaccharide factor |
| Unigene19157_All__1806_348_223 | LG3 | PI3K regulatory subunit α isoform X2 |
| Marker30980_113 | LG15 | Calpain-B-like |
| Marker66_168 | LG33 | Ubiquitin carboxyl-terminal hydrolase |
| Marker17240_299 | LG31 | Forkhead domain-containing protein crocodile-like |
| Marker66_291 | LG33 | Ubiquitin carboxyl-terminal hydrolase |
| Marker4311_49 | LG6 |
|
| ALF6-1__22575_510_224 | LG30 | Anti-lipopolysaccharide factor |
| Marker11943_195 | LG32 | TOM1-like protein 2 |
*LG, linkage group.
Figure 4Expression profile of LvALF6 and LvPI3K regulatory subunit in hepatopancreas, gill, and hemocytes at different times after V. parahaemolyticus infection (P < 0.01). Relative transcription level of LvALF in hepatopancreas (A), gill (B) and hemocytes (C); Relative transcription level of LvPI3K in hepatopancreas (D), gill (E) and hemocytes (F).